KDM1A and neoplasm: The results showed that LSD1 knockdown significantly inhibited tumor growth with a tumor growth inhibition (TGI) of 53.2%, 47.0%, and 44.3% in A2780, SKOV3, and ES2 subcutaneous xenograft models, respectively (Fig. 1j–o).